Recombinant approach to develop ScFv antibodies and vaccines against viral diseases as Ebola, Flu (AH1N1) and Cancer (Polyomavirus)Antibiotic use in relation with long term morbidities
developed through a process of molecular engineering, which begins with in silico bioinformatic processes, using validations and algorithms, subsequently through synthetic biology, molecular biology, genetic…

